z-logo
open-access-imgOpen Access
Mechanisms of drug‐induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo
Author(s) -
Yung Raymond,
Chang Sandra,
Hemati Nahid,
Johnson Kent,
Richardson Bruce
Publication year - 1997
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/art.1780400811
Subject(s) - autoimmunity , systemic lupus erythematosus , in vivo , procainamide , immunology , hydralazine , pharmacology , drug , t cell , medicine , biology , immune system , disease , microbiology and biotechnology , blood pressure
Objective . T cells treated with DNA methylation inhibitors overexpress lymphocyte function‐associated antigen 1 (LFA‐1), which results in autoreactivity, and the autoreactive cells cause a lupus‐like disease in vivo, suggesting a mechanism by which some agents may cause drug‐induced lupus. This study compared the effects of procainamide (Pca) and hydralazine (Hyd) with those of structural analogs, to determine if the degree of LFA‐1 overexpression and T cell autoreactivity correlated with the ability of the agents to induce autoimmunity. Methods . Cloned murine T helper 2 cells were treated with Pca, N ‐acetylprocainamide, Hyd, Phthalazine, or hydroxyurea (HU). The treated cells were then compared for LFA‐1 overexpression, autoreactivity, and the ability to induce autoimmunity in vivo. Results . Pca and Hyd were more potent than their analogs or HU in all 3 assays. Conclusion . The results support a relationship between LFA‐1 overexpression, T cell autoreactivity, and autoimmunity, and suggest a mechanism by which Pca and Hyd, but not the analogs, may cause drug‐induced lupus.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom